Toluene → 4-[4-(3-Piperidin-1-yl-propoxy)-phenyl] piperazine-1-carboxylic acid cyclopropylamide
Reaction equation
[N:1]1([CH2:7][CH2:8][CH2:9][O:10][C:11]2[CH:16]=[CH:15][C:14]([N:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)=[CH:13][CH:12]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[C:23](Cl)(Cl)=[O:24].C1(C)C=CC=CC=1.C(N(CC)CC)C.[CH:41]1([NH2:44])[CH2:43][CH2:42]1>ClCCl>[CH:41]1([NH:44][C:23]([N:20]2[CH2:19][CH2:18][N:17]([C:14]3[CH:15]=[CH:16][C:11]([O:10][CH2:9][CH2:8][CH2:7][N:1]4[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]4)=[CH:12][CH:13]=3)[CH2:22][CH2:21]2)=[O:24])[CH2:43][CH2:42]1Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 1-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperazine (D11) (150 mg, 0.49 mM) in dry dichloromethane (3 ml) was added drop wise a 20% solution of phosgene in toluene (0.5 ml; −2 eq) and the resulting mixture stirred for 1 hour. The solvent was removed by evaporation and the resulting white powder dissolved in dry dichloromethane (4 ml). Triethylamine (0.14 ml: 2 eq) was added followed by cyclopropylamine (0.1 ml; 3 eq) and the mixture stirred for 18 hours. The solvent was removed by evaporation in vacuo and the residue purified on a silica column eluting with 3% methanol in dichloromethane to afford the title compound as a white solid (155 mg) MS (ES+) m/e 387 [M+H]+.
Workup
- customThe solvent was removed by evaporation
- dissolutionthe resulting white powder dissolved in dry dichloromethane (4 ml)
- stirringthe mixture stirred for 18 hours
- customThe solvent was removed by evaporation in vacuo
- customthe residue purified on a silica column
- washeluting with 3% methanol in dichloromethane
Sources & evidence
- ORD record
- ord-54ddf54235e942fd9103ddc6e38f9bd9
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07615550B2
Reaction notes
Loading…